[Diagnosis contribution of biomarkers in Alzheimer disease: A case of frontotemporal dementia].
Rev Neurol (Paris) 2010;
167:160-3. [PMID:
20673934 DOI:
10.1016/j.neurol.2010.06.003]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2010] [Revised: 03/05/2010] [Accepted: 06/07/2010] [Indexed: 11/23/2022]
Abstract
INTRODUCTION
Cerebrospinal fluid biomarkers are a fundamental contribution for the diagnosis of Alzheimer disease, in particular for young people.
CASE REPORT
We report a case of Alzheimer disease of a 51-years old man whose clinical presentation corresponded to frontotemporal behavioural criteria. The clinical evaluation noticed some troubles in verbal memory. Only the CSF biomarkers confirmed the diagnosis.
CONCLUSION
There are different phenotypes of presenile Alzheimer disease and among them we note frontotemporal dementia. It is very important to identify them to introduce a specific treatment.
Collapse